Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma

BACKGROUND: We investigated early outcomes for patients receiving chemotherapy followed by consolidative proton therapy (PT) for the treatment of Hodgkin lymphoma (HL). PATIENTS AND METHODS: From June 2008 through August 2015, 138 patients with HL enrolled on either IRB-approved outcomes tracking pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoppe, B. S., Hill-Kayser, C. E., Tseng, Y. D., Flampouri, S., Elmongy, H. M., Cahlon, O., Mendenhall, N. P., Maity, A., McGee, L. A., Plastaras, J. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834068/
https://www.ncbi.nlm.nih.gov/pubmed/28911093
http://dx.doi.org/10.1093/annonc/mdx287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834068/
https://www.ncbi.nlm.nih.gov/pubmed/28911093
http://dx.doi.org/10.1093/annonc/mdx287

Ejemplares similares